Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project

Paola Bagella,1 Nicola Squillace,2 Elena Ricci,3 Roberto Gulminetti,4 Giuseppe Vittorio De Socio,5 Lucia Taramasso,6 Giovanni Pellicanò,7 Barbara Menzaghi,8 Benedetto Maurizio Celesia,9 Chiara Dentone,10 Giancarlo Orofino,11 Paolo Bonfanti,12 Giordano Madeddu13On behalf of the C.I.S.A.I....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Bagella P, Squillace N, Ricci E, Gulminetti R, De Socio GV, Taramasso L, Pellicanò G, Menzaghi B, Celesia BM, Dentone C, Orofino G, Bonfanti P, Madeddu G
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2019-05-01
Serija:Infection and Drug Resistance
Teme:
HIV-1 infection
dolutegravir/abacavir/lamivudine
lipid profile
Online dostop:https://www.dovepress.com/lipid-profile-improvement-in-virologically-suppressed-hiv-1-infected-p-peer-reviewed-article-IDR
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki